Who
Kim D. Blickenstaff
Director
Company insider
Files Form 4 as: Director, Nuvation Bio; Executive Chairman, Tandem Diabetes Care; Director, Medivation; Director, Senorx; Chairman & CEO, Biosite; Director, DexCom.
In numbers
- Trades disclosed
- 292
- Buys
- 5
- Sells
- 48
- Bought
- $7.0M
- Sold
- $166.7M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 28 Nov 2005
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —123,397 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —123,397 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —292,983 at $0.00 | filing |
| 21 Nov 2024filed 22 Nov 2024 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Sold | $941K30,000 at $31.38 | filing |
| 20 Nov 2024filed 22 Nov 2024 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Sold | $300K10,000 at $30.00 | filing |
| 3 Sep 2024filed 5 Sep 2024 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —200,801 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Bought | $499K172,189 at $2.90 | filing |
| 24 May 2024filed 24 May 2024 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,434 at $0.00 | filing |
| 24 May 2024filed 24 May 2024 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | $229K4,434 at $51.73 | filing |
| 23 May 2024filed 24 May 2024 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,387 at $0.00 | filing |
| 25 May 2023filed 26 May 2023 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,757 at $0.00 | filing |
| 25 May 2023filed 26 May 2023 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —2,757 at $0.00 | filing |
| 24 May 2023filed 26 May 2023 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,434 at $0.00 | filing |
| 15 May 2023filed 17 May 2023 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —366,744 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,757 at $0.00 | filing |
| 18 May 2022filed 19 May 2022 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,205 at $0.00 | filing |
| 18 May 2022filed 19 May 2022 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | —2,205 at $0.00 | filing |
| 17 May 2022filed 19 May 2022 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | $59K6,560 at $9.00 | filing |
| 17 May 2022filed 19 May 2022 | TNDM Tandem Diabetes Careoption or derivative · Medical Devices | SEC FORM 4 Code M | $1000K13,562 at $73.73 | filing |
| 17 May 2022filed 19 May 2022 | TNDM Tandem Diabetes CareMedical Devices | SEC FORM 4 Code M | $59K6,560 at $9.00 | filing |
News
Vontobel Holding Ltd. Sells 14,970 Shares of DexCom, Inc. $DXCMDXCM · dailypolitical.com · 20 Oct 2026Critical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH)NUVB · dailypolitical.com · 18 Oct 2026Tandem Diabetes Care (TNDM) Following App Recall Is The Undervalued Case Still IntactTNDM · cedarnews.net · 18 Oct 2026
0 headlines in the last 90 days name Kim D. Blickenstaff; 3 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.